Tammy Horton/Nikki Ritcher
The Oslo patient is the first person to be cured by a family member's bone marrow transplant.
In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced pancreatic cancer.
New research may hold the key to fixing the genetic error responsible for Down syndrome.